Avian Cholera (Fowl Cholera): A Comprehensive Veterinary Reference
By Dr. Zubair Khalid, DVM, MS, PhD ·
Key Takeaways
- Avian cholera, caused by Pasteurella multocida, is a highly contagious bacterial disease affecting domestic and wild birds, presenting in peracute, acute, or chronic forms with significant morbidity and mortality, particularly in waterfowl, turkeys, and chickens.
- Definitive diagnosis relies on bacterial isolation and identification, with molecular methods like PCR and LAMP offering high sensitivity and specificity, complemented by serological tests such as indirect ELISA for antibody detection.
- Transmission occurs primarily through direct contact with infected birds, contaminated feed and water, or fomites, with outbreaks often triggered by stress factors like overcrowding or concurrent infections.
- Virulence factors of P. multocida include capsular polysaccharides and LPS, with specific genes like hyaD contributing to capsule synthesis, and the bacterium can induce host cell death pathways such as pyroptosis and apoptosis in affected organs like the liver.
- Control strategies integrate strict biosecurity measures, vaccination using inactivated bacterins or live attenuated vaccines, and judicious antimicrobial therapy, though multidrug resistance in P. multocida is a growing concern necessitating susceptibility testing.
- Advanced diagnostic and control approaches include whole-genome sequencing for detailed characterization of isolates, bacteriophage therapy as a biocontrol agent, and the development of subunit vaccines targeting specific virulence proteins.
Introduction
Avian cholera, also termed fowl cholera, is a contagious bacterial disease of domestic and wild birds caused by Pasteurella multocida [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>]. The disease manifests in peracute, acute, or chronic forms and is associated with high morbidity and mortality, particularly in waterfowl, turkeys, and chickens [<a href="#ref-2">2</a>, <a href="#ref-3">3</a>, <a href="#ref-4">4</a>]. Understanding the biological mechanisms of P. multocida pathogenesis and host interactions is essential for effective diagnosis, treatment, and control [<a href="#ref-1">1</a>, <a href="#ref-5">5</a>]. This article provides a detailed veterinary reference on fowl cholera bacterial characteristics, clinical disease, diagnostic approaches, and management strategies, integrating recent genomic and immunological findings.
Etiology and fowl cholera bacterial characteristics
Pasteurella multocida is a Gram-negative, nonmotile, facultatively anaerobic coccobacillus belonging to the family Pasteurellaceae [<a href="#ref-6">6</a>, <a href="#ref-7">7</a>]. The bacterium is classified into five capsular serogroups (A, B, D, E, F) and 16 somatic serotypes, with serogroup A being most commonly associated with avian fowl cholera [<a href="#ref-8">8</a>, <a href="#ref-9">9</a>]. Lipopolysaccharide (LPS) outer core loci exhibit phase variation, contributing to immune evasion and outbreak persistence on free-range layer farms [<a href="#ref-9">9</a>]. Complete genome sequences of multiple isolates representing all LPS outer core loci have been published, facilitating comparative genomic analyses [<a href="#ref-7">7</a>]. In India, fowl cholera (referred to as fowl cholera in Hindi literature) remains a significant constraint to poultry production, with multidrug-resistant type B:2 strains reported in Bangladesh [<a href="#ref-10">10</a>] and widespread ST20 clones detected in Australian poultry farms [<a href="#ref-11">11</a>].
Virulence factors
P. multocida possesses an array of virulence determinants, including capsular polysaccharides, LPS, adhesins, and secreted toxins [<a href="#ref-6">6</a>, <a href="#ref-12">12</a>]. The filamentous hemagglutinin B1 (FhaB1) gene, however, is not involved in avian fowl cholera pathogenesis in turkey poults [<a href="#ref-13">13</a>]. The hyaD gene contributes to virulence by modulating hyaluronic acid capsule synthesis [<a href="#ref-12">12</a>]. In ducks, P. multocida causes liver injury through inflammatory, apoptotic, and autophagic pathways [<a href="#ref-5">5</a>], while in broilers, liver pyroptosis is mediated via the MAPK-NLRP3-GSDMD signaling pathway [<a href="#ref-1">1</a>]. These findings underscore the species-specific molecular pathogenesis of avian pasteurellosis.
Epidemiology
Avian cholera occurs worldwide and affects a broad range of avian hosts, including chickens, turkeys, ducks, geese, and wild birds such as yellow-eyed penguins [<a href="#ref-4">4</a>, <a href="#ref-11">11</a>]. Transmission occurs primarily through direct contact with infected birds, contaminated feed and water, or fomites [<a href="#ref-14">14</a>]. The bacterium can survive in the environment for weeks under favorable conditions, and carrier birds are important reservoirs [<a href="#ref-11">11</a>, <a href="#ref-14">14</a>]. Outbreaks are often precipitated by stress factors such as overcrowding, poor ventilation, or concurrent infections [<a href="#ref-2">2</a>, <a href="#ref-3">3</a>].
A compartmental model of cholera transmission in poultry farms has provided insights into disease dynamics and control strategies [<a href="#ref-14">14</a>]. Coinfection with Mycoplasmoides gallisepticum has been reported to increase mortality in commercial turkey flocks [<a href="#ref-3">3</a>]. In Morocco, an outbreak in turkeys caused by P. multocida serogroup A was characterized by acute mortality [<a href="#ref-8">8</a>]. Strikingly, 100% mortality in commercial slow-growing broilers with acute fowl cholera has been documented [<a href="#ref-2">2</a>].
Clinical signs
Clinical presentation depends on the disease form. Peracute infections cause sudden death with minimal premonitory signs [<a href="#ref-2">2</a>, <a href="#ref-4">4</a>]. Acute avian cholera is characterized by fever, anorexia, depression, mucoid discharge from the mouth and nostrils, increased respiratory rate, cyanosis of the comb and wattles, and diarrhea [<a href="#ref-2">2</a>, <a href="#ref-3">3</a>]. Chronic infections may present with localized swellings of the wattles, joints, foot pads, and sinuses [<a href="#ref-4">4</a>, <a href="#ref-8">8</a>]. In turkeys, coinfection with Mycoplasma gallisepticum exacerbates respiratory signs [<a href="#ref-3">3</a>].
Pathology
Gross lesions in acute fowl cholera include diffuse congestion and petechial hemorrhages on the heart, liver, and serosal surfaces [<a href="#ref-2">2</a>, <a href="#ref-5">5</a>]. The liver often shows multiple focal necrotic foci [<a href="#ref-1">1</a>, <a href="#ref-5">5</a>]. Pneumonia and airsacculitis are common, especially in turkeys [<a href="#ref-3">3</a>, <a href="#ref-8">8</a>]. Microscopically, hepatic pyroptosis and inflammatory infiltration are prominent [<a href="#ref-1">1</a>]. In ducks, liver injury involves hepatocellular apoptosis and autophagic vacuolization [<a href="#ref-5">5</a>]. Chronic cases exhibit caseous or purulent exudate in wattles and joint cavities [<a href="#ref-4">4</a>, <a href="#ref-8">8</a>].
Diagnostics
Definitive diagnosis of fowl cholera relies on bacterial isolation and identification of P. multocida from blood, liver, spleen, or bone marrow [<a href="#ref-8">8</a>, <a href="#ref-15">15</a>]. Molecular methods have largely replaced traditional biochemical typing. A comparative evaluation of PCR and loop-mediated isothermal amplification (LAMP) assays demonstrated high sensitivity and specificity for detecting P. multocida in poultry [<a href="#ref-16">16</a>]. An in-house indirect ELISA kit has been developed and optimized for detection of anti-P. multocida antibodies in chickens [<a href="#ref-17">17</a>]. Whole-genome sequencing provides detailed information on serotype, antimicrobial resistance genes, and phylogenetic relationships [<a href="#ref-7">7</a>, <a href="#ref-18">18</a>].
Diagnostic workflow
Below is a Mermaid diagram representing a typical decision tree for laboratory diagnosis of avian cholera.
graph TD
A["Clinical suspect: acute mortality, lesions"] --> B{"Postmortem samples"}
B --> C["Blood smear / impression smear: bipolar staining"]
B --> D["Culture on blood agar / MacConkey"]
D --> E{"Growth: Gram-negative coccobacilli"}
E --> F["Biochemical confirmation: oxidase +, catalase +, indole +"]
F --> G["Molecular detection: PCR / LAMP / sequencing"]
G --> H["Serotyping: capsular PCR / LPS genotyping"]
H --> I["Antimicrobial susceptibility testing"]
B --> J["Histopathology: liver necrosis, pyroptosis"]
I --> K["Report and control recommendations"]Treatment
Antimicrobial therapy remains the cornerstone of treatment for acute outbreaks, but increasing resistance necessitates susceptibility testing [<a href="#ref-6">6</a>, <a href="#ref-10">10</a>, <a href="#ref-19">19</a>]. Multidrug resistance in avian P. multocida isolates has been documented globally, with resistance genes such as blaROB-1, tet, and sul commonly identified [<a href="#ref-6">6</a>, <a href="#ref-19">19</a>]. Bacteriophage therapy using phage vB_PmuM_CFP3 has shown potential for biocontrol of avian P. multocida [<a href="#ref-20">20</a>]. Natural products such as Egyptian artichoke extract have demonstrated in vitro anti-P. multocida activity [<a href="#ref-21">21</a>]. Multi-strain probiotics have been reported to reduce fowl cholera mortality in broilers [<a href="#ref-22">22</a>].
Control
Biosecurity and management
Strict biosecurity measures, including all-in-all-out production, cleaning and disinfection, and control of rodents and wild birds, are essential to prevent introduction and spread of P. multocida [<a href="#ref-2">2</a>, <a href="#ref-14">14</a>]. Vaccination is a key component of long-term control, especially in endemic areas.
Vaccination
Both inactivated bacterins and live attenuated vaccines are used. Gamma-irradiated vaccines formulated with various adjuvants induce robust antibody responses and cytokine expression in chickens [<a href="#ref-23">23</a>, <a href="#ref-24">24</a>]. A gel 01 hydrogel inactivated vaccine provided immunoprotection against P. multocida infection in chickens [<a href="#ref-25">25</a>]. In Morocco, an autogenous inactivated vaccine prepared from an outbreak isolate effectively reduced mortality in turkeys [<a href="#ref-8">8</a>]. Subunit vaccines based on PlpE multi-epitope proteins [<a href="#ref-26">26</a>] and outer membrane vesicles displaying PlpE [<a href="#ref-27">27</a>] have been developed. Flagellin enhances the immunogenicity of Lipoprotein E subunit vaccine [<a href="#ref-28">28</a>]. Recombinant turkey herpesvirus expressing P. multocida OmpH protein has been evaluated for fowl cholera prevention in ducks [<a href="#ref-29">29</a>]. Attenuation through serial passage yielded a candidate vaccine strain PMZ8 with protective efficacy in ducks [<a href="#ref-30">30</a>]. A truncated LPS mutant strain also induced protective immunity in ducks [<a href="#ref-31">31</a>]. Adjuvants significantly influence the immunogenicity of bacterin vaccines [<a href="#ref-32">32</a>].
For a detailed comparison of vaccine types and administration protocols, refer to the article Fowl Cholera Vaccine: Types, Efficacy, and Administration in Poultry.
Antimicrobial resistance management
Rational use of antimicrobials and routine surveillance of resistance patterns are critical to preserve treatment options [<a href="#ref-6">6</a>, <a href="#ref-10">10</a>, <a href="#ref-19">19</a>]. Genomic characterization of resistance determinants helps guide therapy [<a href="#ref-19">19</a>].
Conclusion
Avian cholera remains a major threat to poultry and wild bird populations worldwide. Advances in molecular diagnostics, genomics, and vaccinology continue to refine our understanding of fowl cholera bacterial pathogenesis and improve control strategies [<a href="#ref-7">7</a>, <a href="#ref-16">16</a>, <a href="#ref-17">17</a>, <a href="#ref-30">30</a>]. Integrated management combining biosecurity, vaccination, and prudent antimicrobial use is essential for sustainable disease control.
For additional information on related topics, consult Avian Cholera (Fowl Cholera): Etiology, Pathogenesis, and Control, Avian Pasteurellosis (Fowl Cholera) in Poultry, and Avian Cholera in Waterfowl.